Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel

Lysosomale saure Lipase

Das LIPA-Gen kodiert eine in Lysosomen wirksame saure Lipase, die für die Aufspaltung der Cholesterolester verantwortlich ist. Mutationen führen zu den autosomal rezessiven Erkrankungen Morbus Wolman und Cholesterolester-Speicherkrankheit.

Gentests:

Forschung Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Wolman-Erkrankung
LIPA
Mangel an lysosomaler saurer Lipase
LIPA

Referenzen:

1.

Anderson RA et al. (1991) Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases.

[^]
2.

Koch G et al. (1981) Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19.

[^]
3.

Warner TG et al. (1980) Separation and characterization of the acid lipase and neutral esterases from human liver.

[^]
4.

Muntoni S et al. (1995) Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).

[^]
5.

Aslanidis C et al. (1994) Genomic organization of the human lysosomal acid lipase gene (LIPA).

[^]
6.

Anderson RA et al. (1994) Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.

[^]
7.

Klima H et al. (1993) A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

[^]
8.

Anderson RA et al. (1993) In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3.

[^]
9.

Muntoni S et al. (1996) A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations.

[^]
10.

Maslen CL et al. (1995) Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease.

[^]
11.

Aslanidis C et al. (1996) Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

[^]
12.

Pagani F et al. (1996) Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.

[^]
13.

Fujiyama J et al. (1996) A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease.

[^]
14.

Lee TM et al. (2011) Intragenic deletion as a novel type of mutation in Wolman disease.

[^]
15.

NCBI article

NCBI 3988 [^]
16.

OMIM.ORG article

Omim 613497 [^]
17.

Orphanet article

Orphanet ID 123063 [^]
Update: 29. April 2019